Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo

Cisplatin is a commonly used chemotherapeutic drug for treatment of oral carcinoma, and combinatorial effects are expected to exert greater therapeutic efficacy compared with monotherapy. Poly(ADP-ribosyl)ation is reported to be involved in a variety of cellular processes, such as DNA repair, cell d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Mol Sci
Hoofdauteurs: Yasukawa, Masaaki, Fujihara, Hisako, Fujimori, Hiroaki, Kawaguchi, Koji, Yamada, Hiroyuki, Nakayama, Ryoko, Yamamoto, Nanami, Kishi, Yuta, Hamada, Yoshiki, Masutani, Mitsuko
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4813136/
https://ncbi.nlm.nih.gov/pubmed/26927065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17030272
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items